The Defender Children’s Health Defense News and Views
Close menu
Close menu

You must be a CHD Insider to save this article Sign Up

Already an Insider? Log in

August 6, 2021 Big Pharma News

Big Pharma

Full Video Testimony: What Did Owner of Purdue Pharma Say About His Family’s Role in Opioid Epidemic?

A settlement is about to shield members of the Sackler family from civil litigation regarding their alleged roles in the opioid crisis — so ProPublica decided now would be good to release the full video of Richard Sackler’s 2015 deposition.

A settlement close to being finalized in a bankruptcy case would provide a shield from civil litigation to the members of the Sackler family who own OxyContin maker Purdue Pharma.

A settlement close to being finalized in a bankruptcy case would provide a shield from civil litigation to the members of the Sackler family who own OxyContin maker Purdue Pharma. The development means that family members will be significantly less likely to be questioned under oath about their role in the marketing of the potent prescription painkiller blamed for fueling a nationwide opioid epidemic.

Despite years of litigation alleging some Sacklers pushed Purdue to aggressively and inappropriately market OxyContin, members of the family successfully avoided most attempts to force them to answer questions about their stewardship of Purdue or the multibillion-dollar fortune they amassed as OxyContin became a bestselling pain medicine.

They have repeatedly denied acting inappropriately, and the settlement under consideration in U.S. Bankruptcy Court in White Plains, New York, does not require the Sacklers to admit wrongdoing. Family members would pay $4.5 billion over nine years to resolve civil lawsuits filed by states, cities, insurers and families impacted by the opioid crisis.

An exception occurred in 2015, when Dr. Richard Sackler was questioned for more than eight hours by lawyers representing the state of Kentucky in a lawsuit against Purdue. Richard Sackler served as president of Purdue Pharma and was a longtime board member.

Purdue fought for years to keep the deposition secret, unsuccessfully appealing the case to the Kentucky Supreme Court after a lower court ruled it should be released. Although a transcript of the deposition was released by a Kentucky court, the video was not. It was obtained in 2019 by ProPublica, which posted selected passages from the video.

In the deposition, Sackler is asked about his role in launching and overseeing the marketing of OxyContin, how Purdue incentivized its sales force to sell the drug, and a decision he supported not to correct the false belief among doctors that OxyContin is weaker than morphine.

With the settlement imminent, we are posting the entire video of the deposition:

Originally published by ProPublica.

Suggest A Correction

Share Options

Close menu

Republish Article

Please use the HTML above to republish this article. It is pre-formatted to follow our republication guidelines. Among other things, these require that the article not be edited; that the author’s byline is included; and that The Defender is clearly credited as the original source.

Please visit our full guidelines for more information. By republishing this article, you agree to these terms.

Woman drinking coffee looking at phone

Join hundreds of thousands of subscribers who rely on The Defender for their daily dose of critical analysis and accurate, nonpartisan reporting on Big Pharma, Big Food, Big Chemical, Big Energy, and Big Tech and
their impact on children’s health and the environment.

  • This field is for validation purposes and should be left unchanged.
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
    MM slash DD slash YYYY
  • This field is hidden when viewing the form